• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
CompaniesAbuse

Employees are cheating on workplace drug tests at record rates—and legalized cannabis could be to blame

Christiaan Hetzner
By
Christiaan Hetzner
Christiaan Hetzner
Senior Reporter
Down Arrow Button Icon
Christiaan Hetzner
By
Christiaan Hetzner
Christiaan Hetzner
Senior Reporter
Down Arrow Button Icon
May 15, 2024, 10:46 AM ET
Man Fills Bong With Cannabis Leaves
A rise in recreational marijuana use in those states that have legalised cannabis is behind tampered drug tests.Getty Images

A rise in the use of recreational marijuana use in states that have legalized cannabis appears to be behind a spike in falsified workplace drug tests. 

Recommended Video

According to figures from Quest Diagnostics cited by the Wall Street Journal, workers are cheating on drug screens at a rate not seen in over 30 years. 

While the number of Americans testing positive for listed substances remains stable for the third year in a row, that is potentially because more are resorting to extreme measures to mask their consumption habits particularly for jobs like heavy machinery operators or vehicle drivers. 

“Some American workers are going to great lengths to attempt to subvert the drug-testing process,” said Suhash Harwani, Quest senior director of science for workforce health solutions, who pointed to pot as the leading cause. 

One increasingly popular method is substituting urine samples to use either someone else’s, synthetic urine that can be purchased online or even animal urine. Quest data showed a sixfold increase last year in substituted samples to mark the highest rate ever recorded by the company.

Another common example that can, however, invalidate results and cause a subject to fail drug screening is not to swap urines but to blend in additives. 

Amphetamines rank second after marijuana

According to Quest, out of more than 8.4 million urine samples tested last year, 4.6% came back positive.

States where recreational marijuana use has been legalized, such as New York and Colorado, have seen the largest swing with 5.8% of the tests positive last year, up from 2.4% in 2015.

By comparison, those states that hadn’t followed saw a much less pronounced increase, with the positivity rate only increasing to 3.3% from 2.6% in 2015.

As a result, employers are reconsidering what drug test policies may need to be changed to reflect the patchwork of different laws on statute books. 

After marijuana, amphetamines rank as the second most common substance to be discovered during drug screening with a positivity rate that increased only marginally to 1.5% last year from 1.3% in 2019. 

Fortune Brainstorm AI returns to San Francisco Dec. 8–9 to convene the smartest people we know—technologists, entrepreneurs, Fortune Global 500 executives, investors, policymakers, and the brilliant minds in between—to explore and interrogate the most pressing questions about AI at another pivotal moment. Register here.
About the Author
Christiaan Hetzner
By Christiaan HetznerSenior Reporter
Instagram iconLinkedIn iconTwitter icon

Christiaan Hetzner is a former writer for Fortune, where he covered Europe’s changing business landscape.

See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.